UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QMN
7376
DELISTED
IQ Hedge Market Neutral Tracker ETF
QMN
| $22K | ﹤0.01% |
831
+167
| +25% | +$4.42K |
|
7377
Acumen Pharmaceuticals
ABOS
$165M
| $21K | ﹤0.01% |
5,245
+4,388
| +512% | +$23.9K |
|
7378
ADMA Biologics
ADMA
$2.25B
| $21K | ﹤0.01% |
+11,395
| New | +$17.8K |
|
7379
Alkami Technology
ALKT
$2.11B
| $21K | ﹤0.01% |
1,462
-2,884
| -66% | -$44K |
|
7380
Arqit Quantum Warrants
ARQQW
$137K
| $21K | ﹤0.01% |
+4,646
| New | +$19.3K |
|
7381
Arts-Way Manufacturing Co
ARTW
$11.1M
| $21K | ﹤0.01% |
3,718
+1,443
| +63% | +$6.23K |
|
7382
AMREP Corp
AXR
$117M
| $21K | ﹤0.01% |
1,558
-30
| -2% | -$385 |
|
7383
BeyondSpring
BYSI
$35.8M
| $21K | ﹤0.01% |
9,581
-15,969
| -63% | -$46.4K |
|
7384
Codexis
CDXS
$159M
| $21K | ﹤0.01% |
1,032
-1,207
| -54% | -$25K |
|
7385
ProShares UltraShort Euro
EUO
$34.8M
| $21K | ﹤0.01% |
762
-1,064
| -58% | -$28.3K |
|
7386
First Trust China AlphaDEX Fund
FCA
$32.9M
| $21K | ﹤0.01% |
804
-320
| -28% | -$8.54K |
|
7387
First Capital
FCAP
$214M
| $21K | ﹤0.01% |
+525
| New | +$21.2K |
|
7388
Immuneering
IMRX
$289M
| $21K | ﹤0.01% |
3,263
+1,643
| +101% | +$15.8K |
|
7389
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$600M
| $21K | ﹤0.01% |
479
-666
| -58% | -$28.9K |
|
|
LOAN
7390
Manhattan Bridge Capital
LOAN
$47.1M
| $21K | ﹤0.01% |
3,378
-4,323
| -56% | -$25K |
|
|
QUCY
7391
Quantum Cyber N.V.
QUCY
$31.4M
| $21K | ﹤0.01% |
36
-182
| -83% | -$112K |
|
7392
NN Inc
NNBR
$298M
| $21K | ﹤0.01% |
7,546
-14,802
| -66% | -$48.7K |
|
7393
Pliant Therapeutics
PLRX
$65M
| $21K | ﹤0.01% |
2,987
-7,334
| -71% | -$74.8K |
|
7394
Patriot National Bancorp
PNBK
$134M
| $21K | ﹤0.01% |
1,205
-159
| -12% | -$2.53K |
|
7395
Global X NASDAQ 100 Tail Risk ETF
QTR
$7.83M
| $21K | ﹤0.01% |
891
+857
| +2,521% | +$19.6K |
|
7396
Scilex Holding
SCLX
$48.8M
| $21K | ﹤0.01% |
59
-29
| -33% | -$10.3K |
|
7397
Seaboard Corp
SEB
$4.1B
| $21K | ﹤0.01% |
5
-18
| -78% | -$69.6K |
|
|
SKYT
7398
DELISTED
SkyWater Technology
SKYT
| $21K | ﹤0.01% |
1,981
-16,185
| -89% | -$178K |
|
7399
Senti Biosciences Holdings
SNTI
$11.2M
| $21K | ﹤0.01% |
+215
| New | +$21.2K |
|
|
SONN
7400
DELISTED
Sonnet BioTherapeutics
SONN
| $21K | ﹤0.01% |
22
+3
| +16% | +$2.54K |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.